ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

Find Full text
Publication year
2019
Author(s)
Thunnissen, E.
Lissenberg-Witte, B.I.
Heuvel, M. van den
Monkhorst, K.
Skov, B.G.
Sorensen, J.B.
Drift, M.A. van der
Looijen-Salamon, M.G.
Wolf, J.
Pauwels, P.
Smit, E.
Source
Lung Cancer, 138, (2019), pp. 13-18
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/214444   https://hdl.handle.net/2066/214444
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.